Original ResearchPublished 25 June 2026Effectiveness and safety of dupilumab in moderate-to-severe atopic dermatitis: a 24- and 48-week cohort from ColombiaJhon Bolaños-López · Carlos Bello · Luz. E. Pérez · Farley González · Sergio Londoño · Yuri Torres · Alejandra ToroFrontiers in Drug Discoverydoi 10.3389/fddsv.2026.1838972